title: Oral administration of myelin induces antigen-specific TGF-beta 1-secreting T cells in multiple sclerosis patients.
authors.affiliation: Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.
authors.forename: S C
authors.initials: SC
authors.lastname: Kent
authors.forename: H
authors.initials: H
authors.lastname: Fukaura
authors.forename: M J
authors.initials: MJ
authors.lastname: Pietrusewicz
authors.forename: S J
authors.initials: SJ
authors.lastname: Khoury
authors.forename: H L
authors.initials: HL
authors.lastname: Weiner
authors.forename: D A
authors.initials: DA
authors.lastname: Hafler
mesh_terms: D000284:Administration, Oral; D000818:Animals; D002460:Cell Line; D016207:Cytokines / Q000378:metabolism; D006801:Humans; D009103:Multiple Sclerosis / Q000276:immunology*; D004676:Myelin Basic Protein / Q000008:administration & dosage* / Q000494:pharmacology; D013601:T-Lymphocytes / Q000276:immunology / Q000378:metabolism*; D016212:Transforming Growth Factor beta / Q000378:metabolism*
chemical_list: D016207:Cytokines; D004676:Myelin Basic Protein; D016212:Transforming Growth Factor beta